In the last three months, 6 analysts have published ratings on BeiGene (NASDAQ:BGNE), offering a diverse range of perspectives from bullish to bearish.

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $212.88, along with a high estimate of $345.00 and a low estimate of $161.00. A decline of 6.98% from the prior average price target is evident in the current average.

Decoding Analyst Ratings: A Detailed Look

The perception of BeiGene by...